Adalat and Ipf - a phase IV clinical study of FDA data

Summary:

Ipf is reported as a side effect among people who take Adalat (nifedipine), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Synthroid, and have Acromegaly.

The phase IV clinical study analyzes which people have Ipf when taking Adalat. It is created by eHealthMe based on reports of 20,643 people who have side effects when taking Adalat from the FDA, and is updated regularly.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

What is Ipf?

Ipf is found to be associated with 2,164 drugs and 2,245 conditions by eHealthMe. Check the latest studies of Ipf.

On Oct, 09, 2025

20,643 people reported to have side effects when taking Adalat.
Among them, 55 people (0.27%) have Ipf.

Among these 55 people:

How long have people been on Adalat when they have Ipf? *

What is the gender of people who have Ipf when taking Adalat? *

female: 60 %
male: 40 %

What is the age of people who have Ipf when taking Adalat? *

What are other drugs people take besides Adalat? *

What are other side effects people have besides Ipf? *

Dyspnea (difficult or laboured breathing): 18 people, 32.73%
Headache (pain in head): 13 people, 23.64%
Nausea (feeling of having an urge to vomit): 12 people, 21.82%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 12 people, 21.82%
Fever: 10 people, 18.18%
Diarrhea: 9 people, 16.36%
Back Pain: 9 people, 16.36%
Pneumonia: 7 people, 12.73%
Nausea And Vomiting: 7 people, 12.73%
Lung Disorder (lung disease): 7 people, 12.73%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 8 people, 14.55%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 9.09%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 9.09%
Stable Angina (a constant chest pain): 4 people, 7.27%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 3 people, 5.45%
Pain: 3 people, 5.45%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 3.64%
Diabetes: 2 people, 3.64%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 3.64%
Lung Adenocarcinoma Metastatic (a form of non-small cell lung cancer spreads to other part): 2 people, 3.64%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat and have Ipf?

- Check whether Ipf is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adalat:

Adalat (20,940 reports)

Ipf treatments and more:

Ipf (79,191 reports)

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ipf:

Ipf (2,164 drugs)

Browse all the conditions that are associated with Ipf:

Ipf (2,245 conditions)

Drugs similar to Adalat and Ipf :

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Adalat) and Adalat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.